O6-Methylguanine-DNA Methyltransferase (O6-MT) Activity as an Index of Drug Responsiveness to Antitumor Chloroethylnitrosoureas in Xenografted Brain Tumors

  • Katsuyoshi Mineura
  • Naoyuki Kuwahara
  • Katsuo Watanabe
  • Masayoshi Kowada


The synthesized chloroethylnitrosoureas (CENUs), 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU), and methyl-6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-α-D-glucopyranoside (MCNU), have been among the antitumor agents widely used for the treatment of malignant brain tumors [1]. Methods for monitoring responsiveness of brain tumors to CENUs on the basis of a cell-killing mechanism have been needed to enhance therapeutic effectiveness. It is well documented that a DNA repair enzyme O6-methylguanine-DNA methyltransferase (O6-MT), identical to the term O6-alkylguanine-DNA alkyltransferase, eliminates the O6-methylguanine induced by CENUs and reflects the cellular resistance to CENUs in cultured cell strains and xenografted tumors [2–5]. Further in vivo work was warranted to establish a chemoserisitivity index of O6-MT activity. In the present paper, we test the relationship of O6-MT activity and responsiveness to CENUs in xenografted brain tumors.


Antitumor Agent Crude Protein Extract Coop Treatment Maximum Inhibition Rate Xenografted Brain Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M, Nomura K (1986) Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53–57PubMedCrossRefGoogle Scholar
  2. 2.
    Scudiero DA, Meyer SA, Clatterbuck BE, Mattern MR, Ziolkowski CHJ (1984) Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Cancer Res 44; 2467–2474PubMedGoogle Scholar
  3. 3.
    Ikenaga M, Tsujimura T, Chang HR, Fujio C, Zhang YP, Ishizaki K, Kataoka H, Shima A (1987) Comparative analysis of O6-methylguanine methyltransferase activity and cellular sensitivity to alkylating agents in cell strains derived from a variety of animal species. Mutat Res 184: 161–168PubMedGoogle Scholar
  4. 4.
    Fujio C, Chang HR, Tsujimura T, Ishizaki K, Kitamura H, Ikenaga M (1989) Hypersensitivity of human tumor xenografts laking O6-alkylguanine-DNA alkyl- transferase to the antitumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea. Carcinogenesis 10: 351–356PubMedCrossRefGoogle Scholar
  5. 5.
    Mineura K, Fushimi S, Kowada M, Isowa G, Ishizaki K, Ikenaga M (1990) Linkage between O6-methylguanine-DNA-methyltransferase activity and cellular resistance to antitumor nitrosoureas in cultured rat brain tumor cell strains. Acta Neurochir (Wien) 103: 62–66CrossRefGoogle Scholar
  6. 6.
    Mineura K, Kuwahara N, Kowada M (to be published) Clinical implication of selective nitrosourea treatment for cerebral gliomas with respect to 06-methyl- guanine-DNA methyltransferase activity. J NeurooncolGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1991

Authors and Affiliations

  • Katsuyoshi Mineura
  • Naoyuki Kuwahara
  • Katsuo Watanabe
  • Masayoshi Kowada
    • 1
  1. 1.Neurosurgical ServiceAkita University HospitalAkita, 010Japan

Personalised recommendations